IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 37 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $0 | – | 2,800 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 2,800 | +55.6% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 1,800 | 0.0% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 1,800 | 0.0% | 0.00% | – |
| Q3 2015 | $1,000 | 0.0% | 1,800 | 0.0% | 0.00% | – |
| Q2 2015 | $1,000 | 0.0% | 1,800 | 0.0% | 0.00% | – |
| Q1 2015 | $1,000 | 0.0% | 1,800 | 0.0% | 0.00% | – |
| Q4 2014 | $1,000 | 0.0% | 1,800 | +80.0% | 0.00% | – |
| Q3 2014 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2014 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2014 | $1,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|